loader
Please Wait
Applying Filters...

Seqens Seqens

X

Product List of all Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Cdymax

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Abacavir (1)

02 Abacavir Sulfate (1)

03 Abiraterone Acetate (1)

04 Alectinib Hydrochloride (1)

05 Atazanavir Sulfate (1)

06 Bictegravir (1)

07 Capecitabine (1)

08 Dabigatran Etexilate Mesylate (1)

09 Daclatasvir (1)

10 Dasatinib (2)

11 Elagolix Sodium (1)

12 Eltrombopag (1)

13 Enzalutamide (1)

14 Erlotinib (1)

15 Erlotinib Hydrochloride (1)

16 Gefitinib (1)

17 Ibrutinib (1)

18 Imatinib Mesylate (2)

19 Isavuconazonium Sulfate (1)

20 Nilotinib (1)

21 Olaparib (1)

22 Oseltamivir Phosphate (1)

23 Palbociclib (1)

24 Pazopanib Hydrochloride (1)

25 Pemetrexed Disodium (1)

26 Ribociclib (1)

27 Ruxolitinib Phosphate (1)

28 Sorafenib (1)

29 Sunitinib (1)

30 Tenofovir Alafenamide Fumarate (1)

31 Tenofovir Disoproxil Fumarate (1)

32 Thiamine Hydrochloride (1)

33 Vitamin B1 (1)

filter

01 Active (8)

02 Blank (27)

filter

01 Valid (3)

02 Blank (32)

filter

01 305MF10101 (1)

02 Blank (34)

filter

01 WC-0327n (7)

02 Blank (28)

URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

36392
Active
SUNITINIB MALATE
2021-10-12
CEP/COS

Close CEP/COS

Japanese DMF

Found JDMF

305MF10101
Sunitinib Malate at No. 77D & 116/1...
2023-08-30
Written Confirmation

Found WC

Indian CDSCO WC-0327n
Valid
Sunitinib Malate
2021-09-01
Application Number
36392
305MF10101
Indian CDSCO WC-0327n
Status
Active
Fees Unpaid
Reviewed
 
Valid
2024-07-15
Filing Details
SUNITINIB MALATE
Sunitinib Malate at No. 77D & 116/1...
Sunitinib Malate
Issue/Submission Date
2021-10-12
2023-08-30
2021-09-01
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

R1-CEP 2013-309 - Rev 03
Valid
Capecitabine
2021-09-08
Japanese DMF

Close JDMF

Written Confirmation

Found WC

Indian CDSCO WC-0327n
Valid
Capecitabin USP/EP/IP/IH
2021-09-01
Application Number
Indian CDSCO WC-0327n
Status
Valid
 
Valid
2024-07-15
Filing Details
Capecitabine
Capecitabin USP/EP/IP/IH
Issue/Submission Date
2021-09-08
2021-09-01
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

35990
Active
DASATINIB [DRUG SUBSTANCE (NON-STER...
2021-06-02
CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Found WC

Indian CDSCO WC-0327n
Valid
Dasatinib IH
2021-09-01
Application Number
35990
Indian CDSCO WC-0327n
Status
Active
Fees Unpaid
Reviewed
 
Valid
2024-07-15
Filing Details
DASATINIB [DRUG SUBSTANCE (NON-STER...
Dasatinib IH
Issue/Submission Date
2021-06-02
2021-09-01
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

36007
Active
ERLOTINIB HYDROCHLORIDE [DRUG SUBST...
2021-06-04
CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Found WC

Indian CDSCO WC-0327n
Valid
Erlotinib Hydrochloride IH
2021-09-01
Application Number
36007
Indian CDSCO WC-0327n
Status
Active
Fees Unpaid
Reviewed
 
Valid
2024-07-15
Filing Details
ERLOTINIB HYDROCHLORIDE [DRUG SUBST...
Erlotinib Hydrochloride IH
Issue/Submission Date
2021-06-04
2021-09-01
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

CEP 2023-221 - Rev 00
Valid
Imatinib mesilate, Process 2
2023-10-30
Japanese DMF

Close JDMF

Written Confirmation

Found WC

Indian CDSCO WC-0327n
Valid
Imatinib Mesilate IH
2021-09-01
Application Number
Indian CDSCO WC-0327n
Status
Valid
 
Valid
2024-07-15
Filing Details
Imatinib mesilate, Process 2
Imatinib Mesilate IH
Issue/Submission Date
2023-10-30
2021-09-01
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

33054
Active
PAZOPANIB HCL (NON-STERILE DRUG SUB...
2018-07-28
CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Found WC

Indian CDSCO WC-0327n
Valid
Pazopanib HCl IH
2021-09-01
Application Number
33054
Indian CDSCO WC-0327n
Status
Active
Fees Unpaid
Reviewed
 
Valid
2024-07-15
Filing Details
PAZOPANIB HCL (NON-STERILE DRUG SUB...
Pazopanib HCl IH
Issue/Submission Date
2018-07-28
2021-09-01
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Found WC

Indian CDSCO WC-0327n
Valid
Abacavir IH
2021-09-01
Application Number
Indian CDSCO WC-0327n
Status
 
Valid
2024-07-15
Filing Details
Abacavir IH
Issue/Submission Date
2021-09-01
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

36670
Active
ABIRATERONE ACETATE
2022-01-06
CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
36670
Status
Active
Fees Unpaid
N/A
 
Filing Details
ABIRATERONE ACETATE
Issue/Submission Date
2022-01-06
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

37942
Active
DASATINIB
2023-01-16
CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
37942
Status
Active
Fees Unpaid
N/A
 
Filing Details
DASATINIB
Issue/Submission Date
2023-01-16
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

37904
Active
ENZALUTAMIDE
2022-12-22
CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
37904
Status
Active
Fees Unpaid
N/A
 
Filing Details
ENZALUTAMIDE
Issue/Submission Date
2022-12-22
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY